Regeneron Pharmaceuticals Common Stock Net 2010-2024 | REGN

Regeneron Pharmaceuticals common stock net for the quarter ending September 30, 2024 was $0.000B, a 0% increase year-over-year.

  • Regeneron Pharmaceuticals common stock net for 2023 was $0B, a 0% decline from 2022.
  • Regeneron Pharmaceuticals common stock net for 2022 was $0B, a 0% decline from 2021.
  • Regeneron Pharmaceuticals common stock net for 2021 was $0B, a 0% decline from 2020.

Regeneron Pharmaceuticals Common Stock Net 2010-2024 | REGN

  • Regeneron Pharmaceuticals common stock net for 2023 was $0B, a 0% decline from 2022.
  • Regeneron Pharmaceuticals common stock net for 2022 was $0B, a 0% decline from 2021.
  • Regeneron Pharmaceuticals common stock net for 2021 was $0B, a 0% decline from 2020.